| 
The Cleveland Clinic Foundation, together
with its institutional partners, Case Western Reserve
University and the University of Cincinnati, and its
commercial partners has received a grant from the state
of Ohio to establish the Atrial Fibrillation Innovation
Center (AFIC), a Wright Center of Innovation. Launched
in the summer of 2005, AFIC falls under Ohio's Third
Frontier human genetics and biomedical engineering initiative,
and is spearheading the charge to address the great
suffering imposed by atrial fibrillation (AF), while
catalyzing an emerging Ohio AF medical device industry.
AFIC represents the largest single government grant
in the world to support Atrial Fibrillation research.
The AFIC's uniquely qualified team —
the nation's largest and most innovative clinical programs,
fundamental researchers and an unrivaled commercialization
group — are jointly implementing an exceptionally
collaborative five-prong research program to ensure
that new AF therapies quickly come to market for the
benefit of AF sufferers. State of the art cardiac mapping
and experimental labs will be utilized by the group
to:
- Develop new surgical treatment technologies.
- Improve catheter-enabled treatment
techniques and instrumentation.
- Conduct basic science and translational
studies into biochemical cellular and genetic causes
for, and treatments of, AF.
- Develop next generation AF treatment
strategies.
- Specify novel patient assessments
to better document therapy outcomes and AF mechanisms.
Alan Bentley
Executive Director, AFIC
bentlea@ccf.org
216-444-6752
Laura Konczos
Program Coordinator
Atrial Fibrillation Innovation Center
konczol@ccf.org
216-445-7006
http://www.clevelandclinic.org/afic/ |
